Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 5
2021 9
2022 3
2023 3
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
Di Nunno V, Lombardi G, Simonelli M, Minniti G, Mastronuzzi A, Di Ruscio V, Corrà M, Padovan M, Maccari M, Caccese M, Simonetti G, Berlendis A, Farinotti M, Pollo B, Antonelli M, Di Muzio A, Dipasquale A, Asioli S, De Biase D, Tosoni A, Silvani A, Franceschi E. Di Nunno V, et al. Among authors: dipasquale a. J Neurooncol. 2024 Mar;167(1):145-154. doi: 10.1007/s11060-024-04589-3. Epub 2024 Mar 8. J Neurooncol. 2024. PMID: 38457090
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram.
Losurdo A, Dipasquale A, Giordano L, Persico P, Lorenzi E, Di Muzio A, Barigazzi C, Korolewicz J, Mehan A, Mohammed O, Scheiner B, Pinato DJ, Santoro A, Simonelli M. Losurdo A, et al. Among authors: dipasquale a. Front Immunol. 2024 Jan 15;15:1323151. doi: 10.3389/fimmu.2024.1323151. eCollection 2024. Front Immunol. 2024. PMID: 38298193 Free PMC article.
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.
Orzan F, De Bacco F, Lazzarini E, Crisafulli G, Gasparini A, Dipasquale A, Barault L, Macagno M, Persico P, Pessina F, Bono B, Giordano L, Zeppa P, Melcarne A, Cassoni P, Garbossa D, Santoro A, Comoglio PM, Indraccolo S, Simonelli M, Boccaccio C. Orzan F, et al. Among authors: dipasquale a. Clin Cancer Res. 2023 Apr 3;29(7):1252-1266. doi: 10.1158/1078-0432.CCR-22-2903. Clin Cancer Res. 2023. PMID: 36648487 Free PMC article.
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.
Caccese M, Simonelli M, Villani V, Rizzato S, Ius T, Pasqualetti F, Russo M, Rudà R, Amoroso R, Bellu L, Bertorelle R, Cavallin F, Dipasquale A, Carosi M, Pizzolitto S, Cesselli D, Persico P, Casini B, Fassan M, Zagonel V, Lombardi G. Caccese M, et al. Among authors: dipasquale a. Cancers (Basel). 2022 May 13;14(10):2425. doi: 10.3390/cancers14102425. Cancers (Basel). 2022. PMID: 35626029 Free PMC article.
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.
Simonelli M, Persico P, Capucetti A, Carenza C, Franzese S, Lorenzi E, Dipasquale A, Losurdo A, Giordano L, Pessina F, Navarria P, Politi LS, Mavilio D, Locati M, Della Bella S, Santoro A, Bonecchi R. Simonelli M, et al. Among authors: dipasquale a. Neurooncol Adv. 2021 Nov 13;3(1):vdab160. doi: 10.1093/noajnl/vdab160. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34901858 Free PMC article.
23 results